The pharmacoepidemiology of COPD

recent advances and methodological discussion

P Burney, S Suissa, J B Soriano, W M Vollmer, G Viegi, S D Sullivan, L M Fabbri, D D Sin, P Ernst, D Coultas, J Bourbeau, D W Mapel, K Weiss, T McLaughlin, David Brendan Price, M C J M Sturkenboom, R Taylor, G W Hagan

Research output: Contribution to journalArticle

39 Citations (Scopus)
Original languageEnglish
Pages (from-to)1s-44s
Number of pages44
JournalEuropean Respiratory Journal
Volume43
Publication statusPublished - 1 Sep 2003

Keywords

  • Age Distribution
  • Aged
  • Aged, 80 and over
  • Cost-Benefit Analysis
  • Europe
  • Female
  • Forecasting
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Pharmacoepidemiology
  • Pulmonary Disease, Chronic Obstructive
  • Quality of Life
  • Respiratory Function Tests
  • Risk Assessment
  • Severity of Illness Index
  • Sex Distribution
  • Survival Analysis
  • United States

Cite this

Burney, P., Suissa, S., Soriano, J. B., Vollmer, W. M., Viegi, G., Sullivan, S. D., ... Hagan, G. W. (2003). The pharmacoepidemiology of COPD: recent advances and methodological discussion. European Respiratory Journal, 43, 1s-44s.

The pharmacoepidemiology of COPD : recent advances and methodological discussion. / Burney, P; Suissa, S; Soriano, J B; Vollmer, W M; Viegi, G; Sullivan, S D; Fabbri, L M; Sin, D D; Ernst, P; Coultas, D; Bourbeau, J; Mapel, D W; Weiss, K; McLaughlin, T; Price, David Brendan; Sturkenboom, M C J M; Taylor, R; Hagan, G W.

In: European Respiratory Journal, Vol. 43, 01.09.2003, p. 1s-44s.

Research output: Contribution to journalArticle

Burney, P, Suissa, S, Soriano, JB, Vollmer, WM, Viegi, G, Sullivan, SD, Fabbri, LM, Sin, DD, Ernst, P, Coultas, D, Bourbeau, J, Mapel, DW, Weiss, K, McLaughlin, T, Price, DB, Sturkenboom, MCJM, Taylor, R & Hagan, GW 2003, 'The pharmacoepidemiology of COPD: recent advances and methodological discussion', European Respiratory Journal, vol. 43, pp. 1s-44s.
Burney P, Suissa S, Soriano JB, Vollmer WM, Viegi G, Sullivan SD et al. The pharmacoepidemiology of COPD: recent advances and methodological discussion. European Respiratory Journal. 2003 Sep 1;43:1s-44s.
Burney, P ; Suissa, S ; Soriano, J B ; Vollmer, W M ; Viegi, G ; Sullivan, S D ; Fabbri, L M ; Sin, D D ; Ernst, P ; Coultas, D ; Bourbeau, J ; Mapel, D W ; Weiss, K ; McLaughlin, T ; Price, David Brendan ; Sturkenboom, M C J M ; Taylor, R ; Hagan, G W. / The pharmacoepidemiology of COPD : recent advances and methodological discussion. In: European Respiratory Journal. 2003 ; Vol. 43. pp. 1s-44s.
@article{965ba3ec2cd14e03978a992b4a91f7e7,
title = "The pharmacoepidemiology of COPD: recent advances and methodological discussion",
keywords = "Age Distribution, Aged, Aged, 80 and over, Cost-Benefit Analysis, Europe, Female, Forecasting, Humans, Incidence, Male, Middle Aged, Pharmacoepidemiology, Pulmonary Disease, Chronic Obstructive, Quality of Life, Respiratory Function Tests, Risk Assessment, Severity of Illness Index, Sex Distribution, Survival Analysis, United States",
author = "P Burney and S Suissa and Soriano, {J B} and Vollmer, {W M} and G Viegi and Sullivan, {S D} and Fabbri, {L M} and Sin, {D D} and P Ernst and D Coultas and J Bourbeau and Mapel, {D W} and K Weiss and T McLaughlin and Price, {David Brendan} and Sturkenboom, {M C J M} and R Taylor and Hagan, {G W}",
year = "2003",
month = "9",
day = "1",
language = "English",
volume = "43",
pages = "1s--44s",
journal = "European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",

}

TY - JOUR

T1 - The pharmacoepidemiology of COPD

T2 - recent advances and methodological discussion

AU - Burney, P

AU - Suissa, S

AU - Soriano, J B

AU - Vollmer, W M

AU - Viegi, G

AU - Sullivan, S D

AU - Fabbri, L M

AU - Sin, D D

AU - Ernst, P

AU - Coultas, D

AU - Bourbeau, J

AU - Mapel, D W

AU - Weiss, K

AU - McLaughlin, T

AU - Price, David Brendan

AU - Sturkenboom, M C J M

AU - Taylor, R

AU - Hagan, G W

PY - 2003/9/1

Y1 - 2003/9/1

KW - Age Distribution

KW - Aged

KW - Aged, 80 and over

KW - Cost-Benefit Analysis

KW - Europe

KW - Female

KW - Forecasting

KW - Humans

KW - Incidence

KW - Male

KW - Middle Aged

KW - Pharmacoepidemiology

KW - Pulmonary Disease, Chronic Obstructive

KW - Quality of Life

KW - Respiratory Function Tests

KW - Risk Assessment

KW - Severity of Illness Index

KW - Sex Distribution

KW - Survival Analysis

KW - United States

M3 - Article

VL - 43

SP - 1s-44s

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

ER -